US Stocks
/
Enliven Therapeutics, Inc. Share Price
Enliven Therapeutics, Inc. Share Price

Enliven Therapeutics, Inc. Share Price

NASDAQ: ELVN | Mid Cap
$40.60
-$0.76 (-1.84%) Last updated on 09 Oct, 2026 | 00:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Enliven Therapeutics, Inc. Stock Performance

Open
$40.22
Prev. Close
$41.36
Circuit Range
N/A
Day Range
$39.33 - $40.70
Year Range
$14.84 - $61.85
Volume
50,017
Average Traded
$39.96

Enliven Therapeutics, Inc. Share Price Today

As of 9 October 2026, Enliven Therapeutics, Inc.'s share price is $40.60. The stock opened at $40.22, compared to its previous close of $41.36. During today's trading session, Enliven Therapeutics, Inc.'s share price traded between $39.33 and $40.70, with an average price of $40.01. Over the past 52 weeks, the stock has recorded a high of $61.85 and a low of $14.84. In terms of performance, Enliven Therapeutics, Inc.'s share price has declined by 1.59% over the last six months and is up 73.21% on a year-on-year basis.

Enliven Therapeutics, Inc. Share Price Chart

$39.33$40.70
L
Show Current Price
H

Enliven Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.30B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.45
Revenue (TTM)
$0.00
Return On Equity (TTM)
-11.83%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-61.24%

Enliven Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$20.15-$29.67-$23.63-$32.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-47.25%20.36%-37.49%

Enliven Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$71.58-$89.02-$103.69
Net Profit MarginN/AN/AN/A
Income ChangeN/A-24.36%-16.48%

About Enliven Therapeutics, Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Enliven Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$45.79
$40.61
-11.49%
Sep 2026
$57.93
$45.88
-24.15%
Aug 2026
$53.50
$60.48
+10.43%
Jul 2026
$51.27
$54.77
+7.92%
Jun 2026
$38.73
$50.75
+28.14%
May 2026
$40.73
$39.60
-4.00%
Apr 2026
$39.57
$41.26
+5.43%
Mar 2026
$29.48
$39.13
+31.80%
Feb 2026
$26.25
$29.69
+12.00%
Jan 2026
$15.34
$26.51
+72.25%
Dec 2025
$20.78
$15.39
-28.75%
Nov 2025
$22.66
$21.60
-7.85%

ELVN Share Price FAQs

What is Enliven Therapeutics, Inc. share price today?

chevron-up
Enliven Therapeutics, Inc. share price today is $40.60 as on October 9, 2026 at 12:29 am IST.

What is the 52 week high and 52 week low of Enliven Therapeutics, Inc. stock?

chevron-up
The 52 week high of Enliven Therapeutics, Inc. stock is $61.85, while the 52 week low is $14.84 as of 9 Oct '26.

What is ELVN's market capitalisation today?

chevron-up
ELVN market capitalisation is $2.30B as of October 9, 2026, at 12:29 am IST.

What is ELVN's net income for the last quarter?

chevron-up
ELVN's net income for the last quarter is -32.49B USD.

What is the 5 year returns of ELVN?

chevron-up
The 5 year returns of ELVN is 181.94% as on 9 Oct '26.

What is the high & low stock price of ELVN today?

chevron-up
ELVN stock price hit a high of $40.70 and low of $39.33 as of 9 Oct '26.

Can I buy ELVN shares in India?

chevron-up
Yes. You can buy ELVN in India by opening an international trading account.